Answers are grounded in this paper and cite their sources.
A rapid emergence of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection (from 26.3% in 1986 to 77% in 2001) was found. The susceptibility of 200 nonduplicate blood isolates of MRSA and 100 MRSA isolates causing refractory bacteremia to 22 antimicrobial agents disclosed that glycopeptides, quinupristin-dalfopristin, and linezolid remained the most active agents.
No takes yet. Share an insight, caveat, or question.
Hsueh et al. (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: